Lawrence D. Kaplan, MD¹, Sin-Ho Jung, PhD^2*, Wendy Stock, M.D.³, Nancy L. Bartlett, MD⁴, Brandelyn Pitcher, MS^2*, John C. Byrd, MD⁵, Kristie A. Blum, MD⁶, Ann S. LaCasce, MD⁷, Noreen Fulton^8*, Eric D. Hsi, MD⁹, David D Hurd, MD¹⁰, Myron Czuczman¹¹, John P. Leonard, MD¹² and Bruce D. Cheson, MD¹³

¹Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
²Alliance Statistics and Data Center, Duke University, Durham, NC
³Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
⁴Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁶Division of Hematology, The Ohio State University, Columbus, OH
⁷Dana-Farber Cancer Institute, Boston, MA
⁸University of Chicago Medical Center, Chicago, IL
⁹Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
¹⁰Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC
¹¹Medical Oncology, Roswell Park Cancer Institute, Buffalo
¹²Department of Medicine, Weill Cornell Medical College, New York, NY
¹³Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

Mary B Callanan, PhD^1,2*, Marie-Hélène Delfau, MD, PhD^3*, Elizabeth Macintyre, MD, PhD⁴, Catherine Thieblemont⁵, Lucie Oberic, MD^6*, Emmanuel Gyan, MD, PhD⁷, Krimo Bouabdallah, MD^8*, Remy Gressin, MD^2,9, Gandhi Damaj, MD, PhD¹⁰, Olivier Casasnovas, MD^11*, Vincent Ribrag, MD¹², Estelle Gimenez, MSc^2,13*, Olivier Hermine^14* and Steven Le Gouill, MD, PhD^15*

¹Laboratoire de Génétique Onco-Hématologique, CHU de Grenoble, GRENOBLE, France
²Centre de Recherche INSERM - Université Joseph Fourier-Grenoble I, U823, Grenoble, France
³Department of Biological Hematology and immunology, Assistance Publique Hopitaux de Paris (APHP), Groupe Hospitalier Mondor, Creteil, France
⁴Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France
⁵Hôpital Saint-Louis, Paris, France
⁶Department of Hematology, Purpan University Hospital, Toulouse, France
⁷Service d’Hématologie et Thérapie Cellulaire, UMR CNRS 7292, CHU de Tours, Tours, France
⁸CHU de Bordeaux, Bordeaux, France
⁹Service d'hématologie clinique, CHU Grenoble, Grenoble, France
¹⁰Hematology Department, CHU Caen, Caen, France
¹¹Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France
¹²DITEP/medicine, Gustave Roussy Cancer Campus, Villejuif, France
¹³Pole Recherche, CHU de Grenoble, Grenoble, France
¹⁴Department of Hematology, Necker Children's hospital, APHP, Paris, France
¹⁵Department of hematology, Nantes university Hospital and UMR892 INSERM, Nantes, France

Jeanette K Doorduijn, MD, PhD¹, Monique C. Minnema, MD, PhD², Marie Jose Kersten, MD, PhD³, Pieternella J Lugtenburg, MD, PhD¹, Martin R. Schipperus, MD, PhD⁴, Marinus van Marwijk Kooy, MD, PhD^5*, Marius MacKenzie, MD. PhD^6*, Josée M Zijlstra, MD, PhD^7*, Henriette W Berenschot, MD^8*, M. R Schaafsma, MD, PhD⁹, Dana A Chitu, PhD^10* and Hanneke C. Kluin-Nelemans, MD, PhD¹¹

¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
²Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, Netherlands
³Hematology, Academic Medical Center, Amsterdam, Netherlands
⁴Haga Teaching Hospital, The Hague, Netherlands
⁵Department of Internal Medicine, Isala Clinic, Zwolle, Netherlands
⁶hematology, UMCN, Nijmegen, Netherlands
⁷Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, Netherlands
⁸Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
⁹Medisch Spectrum Twenthe, Enschede, Netherlands
¹⁰HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹¹Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, Netherlands

Henrik Cederleuf, MD^1*, Martin BjerregÃ¥rd Pedersen, MD, PhD^2*, Mats Jerkeman, MD, PhD³, Thomas Relander, MD, PhD^4*, Francesco d'Amore, MD⁵ and Fredrik Ellin, MD, MSc^6*

¹Department of Oncology, Scania University Hospital, Lund, Lund, Sweden
²Department of Hematology, Aarhus University Hospital, Aarhus C, Denmark
³Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
⁴Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden
⁵Dept. of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁶Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden

Owen A. O'Connor, MD, PhD^1*, Muhit Özcan, MD^2*, Eric D. Jacobsen, MD³, Josep Maria Roncero Vidal, MD^4*, Judith Trotman, MBChB⁵, Judit Demeter, MD, PhD, DsC^6*, Tamás Masszi, MD^7*, Juliana Pereira, MD, PhD^8*, Radhakrishnan Ramchandren, MD^9*, Francesco A. d'Amore, MD, PhD^10*, Francine Foss, MD¹¹, Won-Seog Kim, MD, PhD^12*, John P. Leonard, MD¹³, Carlos Sérgio Chiattone, MD, PhD¹⁴, Pier Luigi Zinzani, MD, PhD¹⁵, Hua Liu, PhD^16*, JungAh Jung, PhD^16*, Xiaofei Zhou, PhD^17*, E. Jane Leonard, MSc^18*, Claudio Dansky Ullmann, MD^18* and Andrei R. Shustov, MD¹⁹

¹Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY
²Department of Hematology & BMT, Ankara University Medical School, Cebeci Hospital, Dikimevi, Ankara, Turkey
³Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Clinical Hematology, Catalan Institute of Oncology, Girona, France
⁵Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
⁶First Department of Internal Medicine, Division of Haematology, Semmelweis University, Budapest, Hungary
⁷Department of Haematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest, Hungary
⁸Department of Hematology, University of São Paulo Medical School, São Paulo, Brazil
⁹Hematology/Oncology, Karmanos Cancer Institute, Detroit, MI
¹⁰Hematology, Aarhus University Hospital, Bethesda, MD
¹¹Yale Hematology/Cutaneous Lymphoma, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT
¹²Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea
¹³Weill Cornell Medical College, New York, NY
¹⁴Department of Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil
¹⁵Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
¹⁶Biostatistics, Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁷Clinical Pharmacology, Millennium Pharmaceuticals Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁸Oncology Clinical Research, Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁹University of Washington Medical Center – Seattle Cancer Care Alliance & Fred Hutchinson Cancer Research Center, Seattle, WA

Kieron Dunleavy, MD¹, Ariela Noy, MD², Jeremy S. Abramson, MD³, Ann S. LaCasce, MD⁴, Brian K Link, MD⁵, Samir Parekh, MD⁶, Deepa Jagadeesh, MD, MPH⁷, Philip J Bierman, MD⁸, Ronald T. Mitsuyasu, MD^9*, Ramakrishna Battini, MD^10*, Peter R Watson, MD^11*, David Peace, MD¹², Bruce J Averbrook, MD^13*, Harris V. Naina, MD¹⁴, Joseph W Leach, MD^15*, Wahid T Hanna, MD¹⁶, Bayard L. Powell, MD¹⁷, Sunil Nagpal, MD^18*, Mark Roschewski, MD¹, Andrea N Lucas, RN^19*, Seth M. Steinberg, PhD^20*, Brad S Kahl, MD²¹, Jonathan W. Friedberg, MD, MMSc²², Richard F Little, MD, MPH²³, Nancy L Bartlett, MD²⁴, Michelle A. Fanale, MD²⁵ and Wyndham H Wilson, MD, PhD¹

¹Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁶Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁸Univ. of Nebraska Medical Center, Omaha, NE
⁹UCLA Medical Center, Los Angeles, CA
¹⁰Department of Oncology, Montefiore Medical Center, New York, NY
¹¹Kinston Medical Specialists, Kinston, NC
¹²Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
¹³Metrohealth Medical Center, Cleveland, OH
¹⁴Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
¹⁵Unity Hospital, Monneapolis, MN
¹⁶University of Tennessee Cancer Institute, Knoxville, TN
¹⁷Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC
¹⁸West Michigan Cancer Center, Kalamazoo, MI
¹⁹Center for Cancer Research, National Cancer Institute, Bethesda, MD
²⁰Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD
²¹Washington University, St.Louis, MO
²²University of Rochester, Rochester, NY
²³Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD
²⁴Washington University School of Medicine, Saint Louis, MO
²⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX